Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT02142218
What this trial is testing

Expanded Access Program With Nivolumab to Treat Melanoma

Who this might be right for
Stage III (Unresectable) or Stage IV Advanced Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Large-scale testing (Phase 3)Active Not RecruitingNCT02224781
What this trial is testing

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+2 more
National Cancer Institute (NCI) 267
Testing effectiveness (Phase 2)Study completedNCT00246012
What this trial is testing

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

Who this might be right for
Melanoma
Centocor, Inc. 144
Not applicableNo Longer AvailableNCT02416232
What this trial is testing

Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00314093
What this trial is testing

RFT-5-dgA in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Texas Southwestern Medical Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT07280832
What this trial is testing

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors

Who this might be right for
Unresectable Locally Advanced or Metastatic MelanomaUnresectable Locally Advanced or Metastatic Urinary Tract Tumors
Shanghai JMT-Bio Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00450255
What this trial is testing

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00072163
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
National Cancer Institute (NCI) 50
Very early researchWithdrawnNCT04223648
What this trial is testing

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Yale University
Very early researchStudy completedNCT02013492
What this trial is testing

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more
William Carson 1
Testing effectiveness (Phase 2)Study completedNCT02581930
What this trial is testing

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Who this might be right for
Metastatic MelanomaRecurrent Cutaneous MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03538314
What this trial is testing

UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Ultimovacs ASA 30
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Not applicableNo Longer AvailableNCT04489433
What this trial is testing

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT05352672
What this trial is testing

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,546
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT03765229
What this trial is testing

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00003646
What this trial is testing

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Vical 78
Testing effectiveness (Phase 2)Study completedNCT00651703
What this trial is testing

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG 21
Next Page